Skip to main content
VIVOZON PHARMACEUTICAL CO., LTD. logo

VIVOZON PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 082800 ISIN · KR7082800004 KO Manufacturing
Open in API
Filings indexed 590 across all filing types
Latest filing 2019-01-02 Regulatory Filings
Country KR South Korea
Listing KO 082800

About VIVOZON PHARMACEUTICAL CO., LTD.

https://www.vivozon.com/

VIVOZON PHARMACEUTICAL CO., LTD. is a research and development company specializing in the discovery and commercialization of innovative drugs, with a primary focus on pain and central nervous system (CNS) diseases. The company utilizes a multi-target drug development platform to create new chemical entities that act on multiple targets to achieve synergistic efficacy. This approach integrates efficacy-based screening from the early stages of discovery to identify candidate substances with a high potential for successful clinical development. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic for post-operative pain management. The company is actively expanding its pipeline to address a broader range of unmet medical needs within the CNS field.

Recent filings

Filing Released Lang Actions
신주인수권행사가액의조정
Regulatory Filings Classification · 95% confidence The document is a formal regulatory announcement regarding the adjustment of the exercise price of warrants (신주인수권행사가액의조정) for Lumimicro. It details the specific changes to the exercise price, the number of exercisable shares, the reasons for the adjustment (capital increase), and the mathematical formulas used for the calculation. This type of filing is a standard corporate disclosure related to capital structure changes and financial instruments, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A or Dividend announcements.
2019-01-02 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party capital increase/share issuance) by Lumi Micro. It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2018-12-26 Korean
타법인주식및출자증권취득결정
Capital/Financing Update Classification · 98% confidence The document is a formal regulatory filing from a Korean company (Lumi Micro) announcing the acquisition of shares in another company (Kumho HT). This type of disclosure, detailing the acquisition of equity in another entity for the purpose of strengthening management control, falls under M&A activity or corporate investment disclosures. In the provided taxonomy, 'TAR' (M&A Activity) is the most appropriate category for announcements regarding mergers, acquisitions, or significant equity investments in other companies.
2018-12-24 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the suspension of share registration (shareholder register closure) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or meeting materials, but rather serves as a formal notice of a corporate action. Since it does not fit into specific categories like dividend announcements or share buybacks, and is a standard regulatory disclosure, it is classified as a general regulatory filing.
2018-12-14 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the company's CEO (Representative Director). It details the outgoing and incoming directors, the reason for the change, and the date of the board resolution. This falls directly under the category of board or management changes.
2018-12-03 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of filing is required under the Capital Markets Act when an entity's shareholding in a listed company changes significantly (crossing thresholds). In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2018-11-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.